Kalaris Therapeutics (KLRS) Total Current Liabilities (2019 - 2020)

Kalaris Therapeutics (KLRS) has 2 years of Total Current Liabilities data on record, last reported at $13.5 million in Q3 2020.

  • For Q3 2020, Total Current Liabilities changed N/A year-over-year to $13.5 million; the TTM value through Sep 2020 reached $13.5 million, changed N/A, while the annual FY2019 figure was $9.1 million, N/A changed from the prior year.
  • Total Current Liabilities reached $13.5 million in Q3 2020 per KLRS's latest filing, up from $8.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $13.5 million in Q3 2020 and bottomed at $8.9 million in Q2 2020.